ArticleFrontiers in immunology2023

Cellular and humoral responses after second and third SARS-CoV-2 vaccinations in patients with autoimmune diseases treated with rituximab: specific T cell immunity remains longer and plays a protective role against SARS-CoV-2 reinfections.

Natalia Egri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.